Hudson Bay Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.86M Hold
650,000
0.02% 404
2025
Q4
$6.82M Hold
650,000
0.02% 413
2025
Q3
$6.73M Hold
650,000
0.02% 469
2025
Q2
$6.7M Hold
650,000
0.02% 472
2025
Q1
$6.55M Buy
+650,000
New +$6.53M 0.02% 530

Other funds holding TDAC

Hudson Bay Capital Management's TDAC Position: Q1 2026 in Review

Hudson Bay Capital Management held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 650,000 shares worth $6.86M. The position accounts for 0.02% of the portfolio, ranked #404.

Hudson Bay Capital Management first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Hudson Bay Capital Management held 650,000 shares of Translational Development Acquisition Corp worth $6.86M as of Q1 2026.
  • Hudson Bay Capital Management left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.02% of Hudson Bay Capital Management's portfolio in Q1 2026, its #404 holding.
  • Hudson Bay Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.